Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors
ClinicalTrials.gov · NCT03917758 · Registry updated: 2020-11-03
- Condition / research focus
- Diabetes Mellitus, Type 2; Arterial Hypertension; Body Weight Changes
- Sponsor
- University of Turin, Italy
- Countries with listed sites
- Italy
- Registry dates and results
- Start: 2018-10-10. Completion: 2020-10-30 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- SGLT2 inhibitor (drug) — also listed as: Dapagliflozin, Empagliflozin, Canagliflozin
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Mauro Maccario
Turin, Piedmont, Italy
Site recruitment: Recruiting